TeamViewer (TMV) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
19 Nov, 2025Executive summary
Q1 2025 delivered 7% year-over-year pro forma revenue growth to €190.3 million, with all regions contributing and enterprise revenue up 22%.
Enterprise segment drove growth, posting a 21% increase in ARR and 20% ARR growth year over year, with NRR at 103%.
Adjusted EBITDA rose 20% year-over-year to €81.7 million, with a margin of 43%, supported by lower marketing spend.
Integration with 1E is progressing well, with new products and cross-selling initiatives launched for both enterprise and SMB customers.
Full-year 2025 guidance is reiterated despite macroeconomic uncertainties and reduced visibility.
Financial highlights
Q1 pro forma revenue reached €190.3 million, up 7% year over year in constant currency.
Pro forma adjusted EBITDA grew 20% year over year to €81.7 million, with a margin of 43% (+4pp year-over-year).
Pro forma adjusted basic EPS increased 30% year over year to €0.29; IFRS EPS was €0.19 (+39%).
Cash conversion for Q1 was 54%, with levered free cash flow after adjustments at €44.5 million (+10%).
Net leverage ratio improved to 3.1x adjusted EBITDA, with net financial debt at €1,027.7 million.
Outlook and guidance
Full-year 2025 ARR expected between €815 million and €840 million, representing 7.5%-10.8% growth.
Full-year pro forma revenue guidance is €778 million to €797 million, or 5.1%-7.7% growth.
Pro forma adjusted EBITDA margin expected to remain around 43% for 2025.
Targeting net leverage ratio below 2.0x by end of 2026.
Revenue phasing anticipates at least €374 million in H1 and at least €104 million in H2.
Latest events from TeamViewer
- 5% revenue and 8% EBITDA growth in 2025; 2026 outlook cautious with 0–3% growth target.TMV
Q4 202510 Feb 2026 - Q2 2024 delivered strong growth, high margins, and reaffirmed full-year guidance.TMV
Q2 20242 Feb 2026 - Enterprise momentum and cost discipline drove strong Q3 growth and profitability.TMV
Q3 202416 Jan 2026 - $720M deal creates a DEX leader, targeting double-digit growth and global expansion by 2027.TMV
M&A Announcement11 Jan 2026 - FY 2024 exceeded guidance with strong Enterprise growth, 1E integration, and margin expansion.TMV
Q4 202416 Dec 2025 - Q2 revenue up 6% and adjusted EBITDA up 17%, driven by enterprise gains and new product launches.TMV
Q2 202516 Nov 2025 - Q3 delivered 4% growth and 46% margin, but 1E weakness led to lower ARR guidance for 2025.TMV
Q3 202522 Oct 2025